Results 81 to 90 of about 197,655 (336)
Primary bone neoplasms in dogs: 90 cases
A retrospective study of necropsy and biopsy cases of 90 primary bone tumors (89 malignant and one benign) in dogs received over a period of 22 years at the Laboratório de Patologia Veterinária, Universidade Federal de Santa Maria, was performed ...
Maria E. Trost +7 more
doaj +1 more source
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley +1 more source
ABSTRACT Background Atypical glandular cells (AGC) in cervical cytology, as defined by the Bethesda System, indicate nuclear atypia beyond reactive changes but without definitive features of malignancy. Although clinically significant because it prompts follow‐up procedures, no quantitative threshold exists for AGC diagnosis.
Havva Gokce Terzioglu +2 more
wiley +1 more source
BCNU (1,3), BIS(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia [PDF]
Howard E. Lessner
openalex +1 more source
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García +17 more
wiley +1 more source
Objetivo: Conhecer a vivência de adultos jovens com câncer durante a pandemia de COVID-19 e o impacto na sua vida psicoemocional. Metodologia: Pesquisa qualitativa, do tipo estudo de caso, cujos dados foram coletados por meio de entrevista ...
Sabrina Nathiéle da Costa Moreira +5 more
doaj +1 more source
Loss of Gastro-intestinal-specific Antigen in Neoplasia [PDF]
R. C. Nairn +3 more
openalex +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source
Inhibition of tumor growth by confrontation with incompatible cells.Possible surveillance mechanism against neoplasia [PDF]
Erna Möller, Göran Möller
openalex +1 more source

